重大资产重组终止。 渤海化学（600800）公告称，公司因筹划出售天津渤海石化有限公司（简称"渤海石化"）100%股权、 通过发行股份及支付现金的方式购买安徽泰达新材料股份有限公司（简称"泰达新材"）的控制权事项， 公司股票于2025年12月8日（星期一）开市起停牌。经审慎研究，公司决定终止本次交易事项，公司股 票自2025年12月22日（星期一）开市起复牌。 南京商旅（600250）也公告，公司于2025年12月19日召开第十一届十七次董事会，审议通过了《关于终 止发行股份及支付现金购买资产并募集配套资金暨关联交易事项并撤回申请文件的议案》《关于与文旅 集团签署 <发行股份及支付现金购买资产协议之解除协议> 的议案》，同意公司终止发行股份及支付现 金购买资产并募集配套资金暨关联交易事项并向上海证券交易所（简称"上交所"）申请撤回本次交易相 关申请文件，并与交易对方签署交易解除协议。 公司表示，自本次交易启动以来，公司及相关各方积极推进各项工作，并严格按照相关规定履行信息披 露义务。由于市场环境及有关情况发生变化，为切实维护公司和广大投资者的利益，经公司审慎研究并 与交易对方友好协商，决定终止本次交易事项并向 ...

Core Viewpoint - Bohai Chemical announced the termination of its planned transaction to sell 100% equity of Tianjin Bohai Petrochemical Co., Ltd. and acquire control of Anhui Taida New Materials Co., Ltd. through a share issuance and cash payment [1][4]. Group 1: Transaction Details - The stock of Bohai Chemical was suspended from trading starting December 8, 2025, and is set to resume trading on December 22, 2025 [1][4]. - The transaction was initially expected to constitute a major asset restructuring as per the regulations, but it would not lead to a change in the actual controller of the company [4]. - The termination was due to the inability of the parties to reach consensus on key terms of the transaction, despite ongoing discussions and negotiations [4][5]. Group 2: Impact and Future Plans - The company stated that the termination of the transaction would not adversely affect its business operations, financial status, or the interests of shareholders, particularly minority shareholders [5][7]. - Bohai Chemical committed to not planning any major asset restructuring for at least one month following the announcement [5][7]. - The company will continue to focus on its core business and seek opportunities for growth in the future [7].

Core Viewpoint - Bohai Chemical announced the termination of its major asset restructuring plan, which involved the sale of 100% equity in Bohai Petrochemical and the acquisition of control over Taida New Materials, due to a lack of consensus on key terms among the parties involved [1][2] Group 1: Restructuring Details - The restructuring plan began on December 5, 2025, with Bohai Chemical signing a letter of intent with its controlling shareholder Bohua Group and Taida New Materials [2] - The transaction consisted of two parts: selling 100% equity of Bohai Petrochemical to Bohua Group and acquiring control of Taida New Materials through share issuance and cash payments [2] - The decision to terminate the restructuring was made to protect the interests of the company and its investors, as the parties could not reach an agreement on core terms [2] Group 2: Financial Performance and Challenges - Bohai Chemical has been facing dual pressure from supply and demand, leading to continuous losses in its propane dehydrogenation (PDH) business [4] - The company reported a revenue of 2.809 billion yuan for the first three quarters of 2025, a year-on-year decrease of 16.82%, with a net loss of 579 million yuan, which has worsened compared to the previous year [4] - The PDH industry is experiencing structural overcapacity, resulting in ongoing profitability issues for Bohai Chemical [4]

Core Viewpoint - Bohai Chemical announced the termination of its major asset restructuring plan, which involved the sale of 100% equity in Bohai Petrochemical and the acquisition of control over Taida New Materials, due to a lack of consensus on key terms among the parties involved [2][3] Group 1: Restructuring Details - The restructuring plan began on December 5, 2025, with Bohai Chemical signing a letter of intent with its controlling shareholder Bohua Group and Taida New Materials [3] - The transaction consisted of two parts: selling 100% equity of Bohai Petrochemical to Bohua Group and acquiring control of Taida New Materials through share issuance and cash payments [3] - The decision to terminate the restructuring was made to protect the interests of the company and its investors, as the parties could not reach an agreement on core terms [3] Group 2: Financial Performance and Challenges - Bohai Chemical has been facing dual pressure from supply and demand, leading to continuous losses in its propane dehydrogenation (PDH) business [5][6] - The company reported a revenue of 2.809 billion yuan for the first three quarters of 2025, a year-on-year decrease of 16.82%, with a net loss of 579 million yuan, which has worsened compared to the previous year [6] - The PDH industry is experiencing structural overcapacity, resulting in ongoing profitability challenges for Bohai Chemical [6]

在经历了长达一年半的筹划和等待后，南京商旅（证券代码：600250）于12月19日晚间突然宣布，由于市场环境及有关情况发生变化，决定终止以发行股 份及支付现金的方式购买南京黄埔大酒店有限公司（以下简称黄埔酒店）100%股权的重大资产重组事项。 【导读】南京商旅终止收购南京黄埔大酒店有限公司100%股权 中国基金报记者 夏天 根据公告，公司已向上交所申请撤回本次交易相关申请文件，并获上交所终止审核的决定。 值得注意的是，就在此次重组终止公告前，12月5日至12月19日的11个交易日里，南京商旅股价上涨幅度超过45%，最新市值达45.35亿元。而重组终止公 告当天，公司股价盘中一度涨停，最终收跌0.14%，报14.60元/股。 重组过程几经波折 回溯公告，南京商旅于2024年5月正式启动此次重大资产重组工作。根据当时的计划，公司拟通过发行股份及支付现金的方式，购买控股股东南京旅游集 团（后更名为南京文旅集团）持有的黄埔酒店100%股权、南京商厦持有的南商运营49%股权。 黄埔酒店是南京市的高端酒店，提供全面的住宿、餐饮和会议服务。此次重组被南京商旅视为完善"旅游+商贸"双主业布局、延伸文商旅产业链的重要举 措。 ...

Core Viewpoint - Sichuan Chengyu aims to expand its revenue channels outside of Sichuan by acquiring high-quality highway assets in Hubei province, with a recent announcement of a cash acquisition of 85% equity in Hubei Jingyi Highway Co., Ltd. for 2.4 billion yuan [2][3] Group 1: Acquisition Details - The acquisition involves Sichuan Chengyu's wholly-owned subsidiary, Sichuan Shunan Investment Management Co., Ltd., purchasing 85% of the equity from Shudao Innovation Investment Development Co., Ltd. for 2.4 billion yuan, based on an assessed value of 2.8 billion yuan for 100% equity [3][4] - Following the completion of this transaction, Jingyi Company will become a subsidiary of Shunan Company and will be included in Sichuan Chengyu's consolidated financial statements [3] Group 2: Financial Performance of Target Company - Jingyi Company, which operates the Jingmen to Yichang section of the G42 highway, reported revenues of 529 million yuan and a profit of 187 million yuan in 2023, with projected revenues of 512 million yuan and a net profit of 192 million yuan for 2024 [4] - For the first seven months of 2025, Jingyi Company achieved revenues of 310 million yuan and a net profit of 149 million yuan [4] Group 3: Legal and Regulatory Context - The previous acquisition attempt was terminated due to legal disputes regarding minority equity, but a final ruling from the Supreme People's Court in November resolved these issues, allowing the current acquisition to proceed [5][6][8] - The legal disputes involved a minority shareholder, Jinhao Group, which held 15% of Jingyi Company, and the resolution of these disputes was crucial for the completion of the acquisition [6][7] Group 4: Strategic Considerations - The decision to switch from a share issuance to a cash acquisition was influenced by shareholder feedback, as issuing new shares could dilute existing shareholders' equity [8]

Core Viewpoint - Sichuan Chengyu aims to expand its revenue channels outside of Sichuan by acquiring high-quality highway assets in Hubei province, with a recent cash acquisition plan for an 85% stake in Hubei Jingyi Highway Co., Ltd. [1][2] Group 1: Acquisition Details - Sichuan Chengyu's wholly-owned subsidiary plans to acquire 85% of Jingyi Highway for 2.4 billion yuan, based on an assessed value of 2.8 billion yuan for 100% equity [2][6] - The acquisition follows a previous failed attempt due to legal disputes over minority shares, which have now been resolved by a final ruling from the Supreme People's Court [1][6] Group 2: Financial Performance of Target Company - Jingyi Highway reported revenues of 529 million yuan and a profit of 187 million yuan in 2023, with projected revenues of 512 million yuan and net profit of 192 million yuan for 2024 [3][6] - The company is expected to generate net profits of 235 million yuan, 247 million yuan, and 270 million yuan from 2026 to 2028, excluding non-recurring gains [6] Group 3: Legal and Shareholder Considerations - The minority shareholder, Jinhao Group, holds 15% of Jingyi Highway and was involved in legal disputes affecting the acquisition process [4][5] - The decision to switch from a share issuance to a cash acquisition was influenced by shareholder feedback, as share issuance could dilute existing shareholders' equity [7]

Core Viewpoint - Bohai Chemical has decided to terminate the major asset sale and related transactions due to the inability to reach an agreement on key terms with the other party, leading to the resumption of its stock trading [1][3][6]. Group 1: Major Asset Sale Termination - The company announced the termination of the plan to sell 100% equity of Tianjin Bohai Petrochemical Co., Ltd. and to acquire control of Anhui Taida New Materials Co., Ltd. through a combination of share issuance and cash payment [3][6]. - The decision was made after both parties failed to agree on essential terms of the transaction [1][6]. Group 2: Stock Resumption - Bohai Chemical's stock will resume trading starting December 22, following the announcement of the termination [2][6]. Group 3: Financial Performance and Business Context - Bohai Petrochemical, established in April 2018, is recognized as a benchmark enterprise in the domestic PDH (Propane Dehydrogenation) sector, with a production capacity of 600,000 tons per year [7]. - The company has been facing long-term operational pressure, with continuous losses reported since 2022, primarily due to the underperformance of its PDH business [8][10]. - The PDH business is currently in a "standstill" state, with maintenance originally planned for 30 days extended due to the need for coordination with new projects in the plant [10]. Group 4: Financial Data Overview - As of the latest financial reports, Bohai Chemical's total revenue for the third quarter of 2025 was 28.09 billion, reflecting a year-on-year decrease of 16.82% [9]. - The company reported a total operating cost of 33.90 billion, leading to an operating loss of 5.76 billion, which is a 7.49% decrease compared to the previous year [9]. - The net profit attributable to shareholders was -5.79 billion, marking a year-on-year decline of 7.85% [9].

Core Viewpoint - Bohai Chemical has decided to terminate the major asset sale and stock repurchase plan due to failure to reach an agreement on key terms of the transaction [2][3][9]. Group 1: Company Actions - On December 19, Bohai Chemical announced the termination of the plan to sell 100% equity of Tianjin Bohai Petrochemical Co., Ltd. and acquire control of Anhui Taida New Materials Co., Ltd. through a share issuance and cash payment [3][9]. - The company's stock will resume trading on December 22, following the announcement [6]. Group 2: Financial Performance - Bohai Chemical has been under long-term operational pressure, with continuous losses since 2022, primarily due to the ongoing losses from its PDH business [10][12]. - The PDH business is currently in a "standstill" state, with maintenance originally planned for 30 days extended due to the need for coordination with new projects, expected to resume production by the end of February 2026 [12]. Group 3: Industry Context - Bohai Petrochemical, established in April 2018, is a benchmark enterprise in the domestic PDH project sector, with a production capacity of 600,000 tons per year [7]. - The company aims to shift from its loss-making PDH business towards fine chemicals, but this plan has now fallen through [9].

Core Viewpoint - Bohai Chemical has decided to terminate the major asset sale and related transactions due to the inability to reach an agreement on key terms of the transaction [5][7]. Group 1: Termination of Major Asset Sale - On December 19, Bohai Chemical announced the termination of the plan to sell 100% equity of Tianjin Bohai Petrochemical Co., Ltd. and to acquire control of Anhui Taida New Materials Co., Ltd. through a combination of issuing shares and cash payment [5][9]. - The decision was made after both parties failed to agree on essential terms of the transaction, leading to a mutual agreement to terminate the deal [7][9]. - Following the announcement, Bohai Chemical committed not to plan any major asset restructuring within one month [7]. Group 2: Stock Resumption - Bohai Chemical's stock will resume trading starting December 22 [3][8]. Group 3: Financial Performance and Business Challenges - Bohai Chemical has faced long-term pressure on its operating performance, with continuous losses since 2022 attributed to the ongoing losses from its PDH business [10][12]. - The company operates a PDH unit that was established in April 2018, which is a key player in the domestic PDH sector, producing propylene used in various chemical products [10]. - The PDH business is currently in a "standstill" state, with maintenance originally planned for 30 days extended due to the need for coordination with new projects, and production is expected to resume by the end of February 2026 [12]. - The company reported a total revenue of 28.09 billion in the latest quarter, reflecting a year-on-year decrease of 16.82% [11].